Skip to main content
OpenTrials

Clinical trial condition

Recurrent Malignant Solid Neoplasm

Explore clinical trials studying Recurrent Malignant Solid Neoplasm. Study availability and eligibility vary by location and protocol.

64 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Malignant Solid Neoplasm trial results

Completed

Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies

NCT02116777

Conditions
Adult Solid Neoplasm, Central Nervous System Neoplasms, Childhood Solid Neoplasm, +16 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
View all 22 locations
View Trial Details
Completed

Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

NCT00939770

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +22 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
View all 28 locations
View Trial Details
Suspended

Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma

NCT06620302

Conditions
Childhood Fibrolamellar Carcinoma, Fibrolamellar hepatocellular carcinoma, Recurrent Childhood Fibrolamellar Carcinoma, +7 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 21 locations
View Trial Details
Suspended

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

NCT04840589

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
Locations
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Mount Sinai Hospital New York, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
View Trial Details

Related conditions